Evidence map›Paper›PMID 17494784›Full record

Trial reportChest2007

Safety of sputum induction with hypertonic saline solution in exercise-induced bronchoconstriction.

Chris Carlsten, Moira L Aitken, Teal S Hallstrand

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in Chest, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Methodological Aspects of Induced Sputum.Advances in respiratory medicine · 2023
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Chris CarlstenDivision of Pulmonary and Critical Care, Department of Medicine, University of Washington, Seattle, WA 98195, USA.
Moira L Aitken
Teal S Hallstrand
University of Washington · US

Funding

AIRWAY INFLAMMATION IN EXERCISE-INDUCED ASTHMAK23HL004231 · NHLBI · UNIVERSITY OF WASHINGTON · PI HALLSTRAND, TEAL S · 2000 to 2004
$621k
NHLBI NIH HHS K23 HL004231NHLBI NIH HHS K23 HL 04231
6 · The paper itself

Abstract

backgroundThe safety of sputum induction (SI) is well described in stable asthma, but the safety of SI in exercise-induced bronchoconstriction (EIB) has not been established.

objectivesOur goals were to examine the relationship between the severity of EIB and bronchoconstriction during SI, and to determine if SI conducted after exercise challenge increases the risk of excess bronchoconstriction during SI.

methodsSI was conducted in 32 patients with mild-to-moderate asthma (baseline FEV(1), 86 +/- 9% of predicted [mean +/- SD]) with EIB (15 to 63% reduction in FEV(1) following exercise challenge) following pretreatment with albuterol using 3% saline solution and repeated on a separate day 30-min after exercise challenge.

resultsThere was a reduction in peak expiratory flow rate (PEFR) during SI without exercise (mean maximum reduction vs baseline, 4.0% at 10 min; 95% confidence interval [CI], 1.0 to 7.1; p = 0.02) and during SI 30 min following exercise (mean maximum reduction vs baseline, 5.2% at 8 min; 95% CI, 1.0 to 7.5; p < or = 0.01); however, there was no difference between the PEFR reductions during SI without or following exercise challenge. The best predictor of reduction in PEFR during SI was the preprocedure FEV(1), while the severity of EIB was not associated with bronchoconstriction during SI.

conclusionsWe conclude that SI can be performed safely following exercise challenge in asthmatics with EIB, and that the severity of EIB prior to SI is not a major determinant of bronchoconstriction during SI.

Indexed as

AdultAlbuterolAsthma, Exercise-InducedBronchoconstrictionBronchodilator AgentsFemaleForced Expiratory VolumeHumansMalePeak Expiratory Flow RateRisk FactorsSaline Solution, HypertonicSeverity of Illness IndexSputumAlbuterolBronchodilator AgentsSaline Solution, Hypertonic

Identifiers

PMID17494784
PMCPMC2048654
OpenAlexW2102790913

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.